Insights

Gathering insights about Opthea…

Similar companies to Opthea

Opthea Tech Stack

Opthea uses 8 technology products and services including Akamai, Cloudflare, OneTrust, and more. Explore Opthea's tech stack below.

Akamai
Content Delivery Network
Cloudflare
Content Management System
OneTrust
Cookie Compliance
Adobe Fonts
Font Scripts
Webpack
Miscellaneous
jQuery Mobile
Mobile Frameworks
WP Engine
Platform As A Service
Slider Revolution
Widgets

Media & News

Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference
Business update to include masked Phase 3 patient demographics and baseline characteristics Presentation on Wednesday, January 15, 2025, 5:15 PM PT in San Francisco, California MELBOURNE, Australia and PRINCETON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that Frederic Guerard, PharmD, Chief Executive Officer, will present at the 43rd Annual J.P.
Dec 19, 2024 | www.globenewswire.com
Opthea's Wet AMD Program to be Featured at FLORetina 2024
MELBOURNE, Australia, and Princeton, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be featured as part of an oral presentation at the annual FLORetina Congress being held on December 5-8, 2024 in Florence, Italy. FLORetina aims to provide cutting-edge insights on research and clinical development from world-leading experts in the field of medical retina, retinal surgery, and imaging.
Nov 26, 2024 | www.globenewswire.com
Opthea Appoints Kathy Connell to Board of Directors
Ms. Connell is a commercial executive with business development expertise Appointment takes place as Opthea prepares for Phase 3 wet AMD topline data in 2025 MELBOURNE, Australia, and PRINCETON, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment of Kathy Connell, GAICD, to the Board of Directors (the “Board”) as a Non-Executive Director.
Nov 15, 2024 | www.globenewswire.com
Opthea Wet AMD Program to be Presented at Innovate Retina
MELBOURNE, Australia, and Princeton, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be highlighted during the Innovate Retina Meeting on October 17, 2024, in Chicago, Illinois.
Oct 10, 2024 | www.globenewswire.com
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
MELBOURNE, Australia and PRINCETON, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that management will participate in a fireside chat and be available for one-on-one investor meetings at the UBS Virtual Ophthalmology Day 2024 being held on October 2, 2024.
Sep 30, 2024 | www.globenewswire.com
Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept
Three consecutive commercial-scale batches successfully produced Major milestone for potential BLA filing of sozinibercept in wet AMD Progress update of drug product PPQ campaign expected in early 2025 MELBOURNE, Australia and PRINCETON, N.J., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the completion of its drug substance Process Performance Qualification (PPQ) campaign for sozinibercept.
Sep 18, 2024 | www.globenewswire.com
Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight
MELBOURNE, Australia and PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced scientific presentations and a non-CME educational lunch symposium highlighting sozinibercept's potential to become the first therapy in 20 years to improve visual outcomes in wet AMD patients at the European Society of Retina Specialists Annual Conference -- EURETINA Innovation Spotlight (EIS), September 18, 2024, and the 24th EURETINA Congress, September 19-22, 2024, being held at the CCIB in Barcelona, Spain.
Sep 10, 2024 | www.globenewswire.com

Opthea's Email Address Formats

Opthea uses at least 1 format(s):

Opthea Email Formats	Example	Percentage
First.Last@opthea.com	John.Doe@opthea.com	48%
FirstLast@opthea.com	JohnDoe@opthea.com	2%
First.Last@opthea.com	John.Doe@opthea.com	48%
FirstLast@opthea.com	JohnDoe@opthea.com	2%

Frequently Asked Questions

Where is Opthea's headquarters located?

Opthea's main headquarters is located at Suite 0403, Level 4, 650 Chapel Street Toorak South Yarra, VIC 3141 AU. The company has employees across 5 continents, including North AmericaOceaniaEurope.

What is Opthea's phone number?

You can contact Opthea's main corporate office by phone at

+61-3-9826-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Opthea's stock symbol?

Opthea is a publicly traded company; the company's stock symbol is OPT.

What is Opthea's official website and social media links?

Opthea's official website is opthea.com and has social profiles on LinkedIn.

How much revenue does Opthea generate?

As of November 2024, Opthea's annual revenue reached $3.8M.

What is Opthea's SIC code NAICS code?

Opthea's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Opthea have currently?

As of November 2024, Opthea has approximately 51 employees across 5 continents, including North AmericaOceaniaEurope. Key team members include Chief Executive Officer: F. G.Chief Commercial Officer (cco): M. C.Chief Financial Officer: T. R.. Explore Opthea's employee directory with LeadIQ.

What industry does Opthea belong to?

Opthea operates in the Biotechnology Research industry.

What technology does Opthea use?

Opthea's tech stack includes AkamaiCloudflareOneTrustAdobe FontsWebpackjQuery MobileWP EngineSlider Revolution.

What is Opthea's email format?

Opthea's email format typically follows the pattern of . Find more Opthea email formats with LeadIQ.

How much funding has Opthea raised to date?

As of November 2024, Opthea has raised $114M in funding. The last funding round occurred on Jun 12, 2024 for $114M.

When was Opthea founded?

Opthea was founded in 2012.

Opthea

Biotechnology ResearchVictoria, Australia51-200 Employees

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).

Opthea’s lead product candidate, sozinibercept, is being evaluated in two pivotal Phase 3 clinical trials (COAST, NCT04757636, and ShORe, NCT04757610) for use in combination with standard-of-care anti-VEGF-A monotherapies to improve overall efficacy and deliver superior vision gains compared to standard-of-care anti-VEGF-A agents. To learn more, visit our website and follow us on X and LinkedIn.
Enquiries can be directed to: info@opthea.com

Company Overview

Headquarters: Suite 0403, Level 4, 650 Chapel Street Toorak South Yarra, VIC 3141 AU
Phone number: +61-3-9826-****
Website: opthea.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: OPT
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2012
Employees: 51-200

Media & News

Funding & Financials

$114M
Opthea has raised a total of $114M of funding over 6 rounds. Their latest funding round was raised on Jun 12, 2024 in the amount of $114M.
$10M
Opthea's revenue is in the range of $10M

Funding & Financials

$114M
Opthea has raised a total of $114M of funding over 6 rounds. Their latest funding round was raised on Jun 12, 2024 in the amount of $114M.
$10M
Opthea's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Opthea

Roche

Bristol Myers Squibb

Sanofi

Johnson & Johnson

Allergan

Merck

Novo Nordisk

Pfizer

AstraZeneca

AbbVie

Biogen

Novartis

Bayer

Opthea Tech Stack

Media & News

Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference

Opthea's Wet AMD Program to be Featured at FLORetina 2024

Opthea Appoints Kathy Connell to Board of Directors

Opthea Wet AMD Program to be Presented at Innovate Retina

Opthea to Participate in the UBS Virtual Ophthalmology Day 2024

Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept

Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight

Opthea's Email Address Formats

Frequently Asked Questions

Where is Opthea's headquarters located?

What is Opthea's phone number?

What is Opthea's stock symbol?

What is Opthea's official website and social media links?

How much revenue does Opthea generate?

What is Opthea's SIC code NAICS code?

How many employees does Opthea have currently?

What industry does Opthea belong to?

What technology does Opthea use?

What is Opthea's email format?

How much funding has Opthea raised to date?

When was Opthea founded?

Opthea

Company Overview

Media & News

Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference

Opthea's Wet AMD Program to be Featured at FLORetina 2024

Opthea Appoints Kathy Connell to Board of Directors

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?